RecruitingNCT06332742
Real-world Evaluation of Qingxin Zishen Decoction on Ovarian Reserve Function Clinical Efficacy in Patients With Decreased
Real-world Evaluation of the Clinical Efficacy of Qingxin Zishen Decoction in Patients With Reduced Ovarian Reserve
Sponsor
Yun Chen
Enrollment
178 participants
Start Date
Nov 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
A prospective cohort study evaluated the clinical efficacy of Qingxin Zishen Decoction
Eligibility
Sex: FEMALEMin Age: 25 YearsMax Age: 45 Years
Plain Language Summary
Simplified for easier understanding
This Chinese observational study is evaluating whether a traditional herbal medicine called Qingxin Zishen Decoction can improve ovarian reserve function in women with decreased ovarian reserve — a condition where the ovaries have fewer eggs than expected for a woman's age. Decreased ovarian reserve is measured by low levels of anti-Müllerian hormone (AMH), low antral follicle count on ultrasound, and elevated FSH levels. Women aged 25 to 45 with confirmed decreased ovarian reserve based on these markers can participate, though those whose ovarian decline was caused by surgery, radiation, or chemotherapy, or who have used hormone-affecting drugs in the past 3 months, are not eligible. Participation involves taking the herbal decoction as directed and attending regular follow-up visits for hormonal and ultrasound assessments. This summary was prepared with AI assistance to help patients understand the study in plain language.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06332742